Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

UNC-GRK4-1: An Allele Specific Cancer Testis Antigen Identified Through Genomic Screening

Udara Dharamsiri, PhD, Sally A. Hunsucker, PhD, Benjamin G. Vincent, MD, Michael Wu, PhD, Edward J. Collins, PhD, Shoudan Liang, PhD, Jeffrey J. Molldrem, MD, Paul M. Armistead, MD, PhD

Blood (2013) 122 (21): 3246.

https://doi.org/10.1182/blood.V122.21.3246.3246

Published: 2013

Journal Articles

RNA-Seq Expression Profiling of AML Stem Cells Reveals Differential Expression of Lineage Differentiation Markers and Novel Splice Variants.

Benjamin G Vincent, MD, Darshan Singh, MS, Michael Wu, PhD, Sally A. Hunsucker, PhD, Gheath Alatrash, DO, PhD, Kathryn Ruisaard, MS, Pariya Sukhumalchandra, BS, Karen Clise-Dwyer, PhD, Jonathan S Serody, MD, Jan F Prins, PhD, Jeffrey J. Molldrem, M.D., Paul M. Armistead, MD, PhD

Blood (2012) 120 (21): 2502.

https://doi.org/10.1182/blood.V120.21.2502.2502

Published: 2012

Journal Articles

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens (SL) for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease.

Kikuchi Takahide, MD, Pablo Miguel Parker, MD, Michael Wu, MD, Paul A. Carpenter, MD, Barbara Stehr, ARNP, Perry Rosenthal, MD, Paul J. Martin, MD, Stephen J. Forman, MD, Mary E.D. Flowers, MD

Blood (2006) 108 (11): 2913.

https://doi.org/10.1182/blood.V108.11.2913.2913

Published: 2006

Journal Articles

Phase II Trial of Abbreviated CHOP-Rituximab Followed by 90 Y Ibritumomab Tiuxetan (Zevalin) and Rituximab in Patients with Previously-Untreated Follicular Non-Hodgkin Lymphoma (NHL).

Nicholas A. DeMonaco, MD, Michael Wu, MD, Jennifer Osborn, MD, Terry Evans, MD, Kenneth A. Foon, MD, Steven H. Swerdlow, MD, Jeffrey Kant, MD, PhD, Judith Joyce, MD, Stephanie R. Land, PhD, Samuel A. Jacobs, MD

Blood (2005) 106 (11): 2449.

https://doi.org/10.1182/blood.V106.11.2449.2449

Published: 2005

Journal Articles

Alternative splicing of protein 4.1R exon 16: ordered excision of flanking introns ensures proper splice site choice

Sherry L. Gee, Kazuko Aoyagi, Robert Lersch, Victor Hou, Michael Wu, John G. Conboy

Blood (2000) 95 (2): 692–699.

https://doi.org/10.1182/blood.V95.2.692

Published: 2000

NARROW

UNC-GRK4-1: An Allele Specific Cancer Testis Antigen Identified Through Genomic Screening

RNA-Seq Expression Profiling of AML Stem Cells Reveals Differential Expression of Lineage Differentiation Markers and Novel Splice Variants.

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens (SL) for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease.

Phase II Trial of Abbreviated CHOP-Rituximab Followed by 90 Y Ibritumomab Tiuxetan (Zevalin) and Rituximab in Patients with Previously-Untreated Follicular Non-Hodgkin Lymphoma (NHL).

Alternative splicing of protein 4.1R exon 16: ordered excision of flanking introns ensures proper splice site choice

Email alerts

ASH Publications

American Society of Hematology

UNC-GRK4-1: An Allele Specific Cancer Testis Antigen Identified Through Genomic Screening

RNA-Seq Expression Profiling of AML Stem Cells Reveals Differential Expression of Lineage Differentiation Markers and Novel Splice Variants.

Use of Fluid-Ventilated, Gas-Permeable Scleral Lens (SL) for Management of Severe Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease.

Phase II Trial of Abbreviated CHOP-Rituximab Followed by 90 Y Ibritumomab Tiuxetan (Zevalin) and Rituximab in Patients with Previously-Untreated Follicular Non-Hodgkin Lymphoma (NHL).

Alternative splicing of protein 4.1R exon 16: ordered excision of flanking introns ensures proper splice site choice

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only